1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. United States >
  6. Connecticut >
  7. Biohaven Pharmaceutical Holding >
  8. M&A

Biohaven Pharmaceutical Holding Mergers & Acquisitions

Biohaven Pharmaceutical Holding M&A Summary

Biohaven Pharmaceutical Holding has acquired 1 company of its own, including 1 in the last 5 years.

Biohaven Pharmaceutical Holding’s largest acquisition to date was in 2022, when it acquired Channel Biosciences for $100M. Biohaven Pharmaceutical Holding has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Biohaven Pharmaceutical Holding

Biohaven Pharmaceutical Holding Co. Ltd.

215 Church Street,
New Haven, Connecticut 06510
United States,
(203) 404-0410
www.biohavenpharma.com

All (1) Buy (1) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2022-02-25 Channel Biosciences · Life Science
Pittsburgh, Pennsylvania

Channel Biosciences is a developer of the Kv7 platform and BHV-7000 is a potent activator of Kv7.2/Kv7.3, key subunits involved in neuronal signaling and in regulating the hyperexcitable state in epilepsy.

100 Divestiture

Biohaven Pharmaceutical Holding

Knopp Biosciences


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal